6.5. Analysis.

Comparison 6 ICS versus placebo, studies of COPD with BHR, greater than 6 months (all doses), Outcome 5 Change in log10 PC20 histamine.

Comparison 6 ICS versus placebo, studies of COPD with BHR, greater than 6 months (all doses), Outcome 5 Change in log10 PC20 histamine.